US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 7.590
  • -0.290-3.68%
Close Mar 28 16:00 ET
  • 7.590
  • 0.0000.00%
Post 20:01 ET
809.32MMarket Cap-2.78P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.22%273.21M
-0.92%62.69M
6.11%69.42M
7.21%73.71M
8.33%67.38M
16.00%259.66M
-7.73%63.28M
11.87%65.43M
26.83%68.76M
46.12%62.19M
Selling and administrative expenses
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
-General and administrative expense
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
Research and development costs
-8.10%171.24M
-10.51%37.36M
-9.67%42.32M
-9.80%46.35M
-2.47%45.23M
12.55%186.34M
-16.57%41.74M
7.98%46.84M
24.25%51.38M
50.58%46.37M
Operating profit
-5.22%-273.21M
0.92%-62.69M
-6.11%-69.42M
-7.21%-73.71M
-8.33%-67.38M
-16.00%-259.66M
7.73%-63.28M
-11.87%-65.43M
-26.83%-68.76M
-46.12%-62.19M
Net non-operating interest income expense
2.81%14.46M
-34.60%2.37M
-23.37%2.71M
33.05%4.07M
37.89%5.32M
610.30%14.06M
94.67%3.62M
382.24%3.53M
1,691.67%3.06M
1,023.21%3.86M
Non-operating interest income
2.55%16.35M
-30.55%2.84M
-20.58%3.18M
28.75%4.54M
33.86%5.79M
309.85%15.94M
228.43%4.09M
195.57%4M
426.76%3.52M
594.54%4.33M
Non-operating interest expense
0.59%1.89M
0.64%473K
0.43%471K
0.64%471K
0.64%471K
-1.78%1.88M
176.55%470K
-24.48%469K
-45.64%468K
-55.04%468K
Other net income (expense)
Income before tax
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Income tax
Net income
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Net income continuous Operations
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Minority interest income
Net income attributable to the parent company
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Basic earnings per share
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
Diluted earnings per share
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.22%273.21M-0.92%62.69M6.11%69.42M7.21%73.71M8.33%67.38M16.00%259.66M-7.73%63.28M11.87%65.43M26.83%68.76M46.12%62.19M
Selling and administrative expenses 39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M
-General and administrative expense 39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M
Research and development costs -8.10%171.24M-10.51%37.36M-9.67%42.32M-9.80%46.35M-2.47%45.23M12.55%186.34M-16.57%41.74M7.98%46.84M24.25%51.38M50.58%46.37M
Operating profit -5.22%-273.21M0.92%-62.69M-6.11%-69.42M-7.21%-73.71M-8.33%-67.38M-16.00%-259.66M7.73%-63.28M-11.87%-65.43M-26.83%-68.76M-46.12%-62.19M
Net non-operating interest income expense 2.81%14.46M-34.60%2.37M-23.37%2.71M33.05%4.07M37.89%5.32M610.30%14.06M94.67%3.62M382.24%3.53M1,691.67%3.06M1,023.21%3.86M
Non-operating interest income 2.55%16.35M-30.55%2.84M-20.58%3.18M28.75%4.54M33.86%5.79M309.85%15.94M228.43%4.09M195.57%4M426.76%3.52M594.54%4.33M
Non-operating interest expense 0.59%1.89M0.64%473K0.43%471K0.64%471K0.64%471K-1.78%1.88M176.55%470K-24.48%469K-45.64%468K-55.04%468K
Other net income (expense)
Income before tax -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Income tax
Net income -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Net income continuous Operations -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Minority interest income
Net income attributable to the parent company -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Basic earnings per share 6.51%-2.733.13%-0.625.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73
Diluted earnings per share 6.51%-2.733.13%-0.625.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Earnings Season Underway
Earnings season is here. What to know?